Inactive Instrument

News Cynosure, Inc.

Stocks

US2325772059

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq
- ^USD	-

All News

Mentions Relevance

17-02-16	Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	BU
17-02-16	CYNOSURE, INC. Former SEC Attorney Willie Briscoe Believes the Acquisition by Hologic, Inc. May be Unfair to Shareholders	BU
17-02-15	Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Investors To Contact The Firm For Additional Information	BU
17-02-14	CYNOSURE, INC. Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
17-02-14	CYNOSURE (CYNO) Alert: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Cynosure, Inc.	PR
17-02-14	Cynosure : Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses	PR
17-02-07	Cynosure : Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year	PU
17-01-06	Cynosure : to Host Fourth-Quarter 2016 Financial Results Conference Call on February 7	PR
16-12-05	Cynosure : Recognized Among Deloitte's 2016 Technology Fast 500(TM)	PR
16-11-29	Cynosure : Receives CFDA Clearance to Market the Icon™ Aesthetic System in China	PU
16-11-29	Cynosure : Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China	PR
16-11-10	Cynosure : to Participate in Stifel 2016 Healthcare Conference	PR
16-10-25	Cynosure : Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million	PU
16-10-11	Cynosure : To Host Third-Quarter 2016 Financial Results Conference Call On October 25	PR
16-09-30	Cynosure : Recognized as One of FORTUNE's 100 Fastest-Growing Companies	PR
16-09-13	Cynosure : to Name Stephen J. Webber as New Chief Financial Officer	PR
16-07-26	Cynosure : Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016	PU
16-07-26	Cynosure : Receives Approval to Market SculpSure® in South Korea	PR
16-07-23	Cynosure : To Host Second-Quarter 2016 Financial Results Conference Call On July 26	PU
16-07-14	Cynosure : To Host Second-Quarter 2016 Financial Results Conference Call On July 26	PR
16-07-13	Cynosure : Receives Health Canada Authorization to Market SculpSure®	PR
16-06-16	Cynosure : to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary	PR
16-05-25	Cynosure : Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer	PR
16-05-24	Cynosure : Receives FDA Clearance to Market New PicoSure® Energy Delivery System for Tattoos and Pigmented Lesions	PU
16-04-26	Cynosure : Announces Record First-Quarter 2016 Results; Revenues Increase 26% from Prior Year to $94.7 Million	PU